Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting News Coverage

Regorafenib improved survival, delayed progression in colorectal cancer

January 26, 2012
2012 Gastrointestinal Cancers Symposium SAN FRANCISCO — The investigational drug regorafenib extended survival in patients with …
Meeting News Coverage

NO16968: Xelox improved 7-year OS in advanced colon cancer

January 23, 2012
2012 Gastrointestinal Cancers Symposium SAN FRANCISCO — Patients with stage III colon cancer assigned to Xelox realized a significant improvement…
Meeting News CoveragePerspective

GRANITE-1: Second-line everolimus did not extend OS for advanced gastric cancer

January 20, 2012
2012 Gastrointestinal Cancers Symposium SAN FRANCISCO — Patients assigned to everolimus monotherapy did not enjoy a survival benefit, according to…
Meeting News CoverageMeeting HighlightsPerspective

Inappropriate use of medical imaging may be more widespread than previously thought

HemOnc Today, March 25, 2011
ASCO 2011 Genitourinary Cancers Symposium ORLANDO — More than one-third of men at low risk for prostate cancer underwent unnecessary medical…
Meeting News CoverageMeeting Highlights

Higher baseline PSA may be linked to increased prostate cancer risk

HemOnc Today, March 10, 2011
ASCO 2011 Genitourinary Cancers Symposium ORLANDO — The risk for prostate cancer and aggressive prostate cancer increased as PSA scores increased…
Meeting News CoverageMeeting Highlights

Dutasteride may increase adherence to active surveillance in early stage prostate cancer

HemOnc Today, March 10, 2011
ASCO 2011 Genitourinary Cancers Symposium ORLANDO — Dutasteride increased adherence to active surveillance by nearly 40% in a cohort of men with…
Meeting News CoverageMeeting Highlights

More time may be required to reach expert level in robotic prostate surgery

HemOnc Today, March 10, 2011
ASCO 2011 Genitourinary Cancers Symposium ORLANDO — Surgeons may need to perform more than 1,500 robotic-assisted laparoscopic radical…
Meeting News CoverageMeeting HighlightsPerspective

Bicalutamide during and after radiation shows promise for post-radical prostatectomy

HemOnc Today, March 10, 2011
ASCO 2011 Genitourinary Cancers Symposium ORLANDO — The addition of bicalutamide to radiation therapy significantly improved OS and freedom from…
Meeting News CoverageMeeting HighlightsPerspective

Intermittent androgen suppression may be noninferior to continuous androgen deprivation

HemOnc Today, March 10, 2011
ASCO 2011 Genitourinary Cancers Symposium ORLANDO — Intermittent androgen suppression therapy yielded similar OS outcomes as continuous androgen…
Meeting News CoverageMeeting HighlightsPerspective

FOLFOX plus cetuximab produced ORR of 77% in cardia, esophageal cancer

HemOnc Today, February 25, 2011
2011 Gastrointestinal Cancers Symposium SAN FRANCISCO – Chemoradiation with FOLFOX and cetuximab was effective in adults with locally advanced…